Stay updated with breaking news from Peter Demuth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaccines that target tumors with specific genetic mutations in pancreatic and other cancers have shown promise in early-stage trials
Published data shows lymph node-targeted Amphiphile -peptide and CpG combination with TCR-T cell therapy led to complete eradication and durable responses against established murine solid tumors...
The road to effective cancer vaccines has been long and difficult. Although initial attempts to use a vaccine to treat cancer date back to the 1910s, the first effective therapeutic vaccine would not emerge until about a century later, when Sipuleuce
At a pivotal moment in cancer vaccine research, the MIT Koch Institute Annual Symposium explored emerging successes and obstacles in the field in areas that include immunology, next-generation tools and models, and mRNA and other vaccine platforms.
The new vaccine candidate offers a breakthrough approach that combines two powerful arms of the immune system to target Epstein–Barr virus in both acute and latent infection.